Rentokil Rises After Goldman Sachs Upgrade
Introduction: The Tuesday When the Rats Retreated
Tuesday, London Stock Exchange. Shares of Rentokil Initial PLC, a company known across Britain — from housewives to restaurant owners — unexpectedly came back to life. While the FTSE 100 index remained almost unchanged, Rentokil rose by 2.1%, climbing to 453.5 pence per share. The reason behind the move was an upgrade from Goldman Sachs.
Goldman Sachs, one of the world’s leading investment banks, upgraded Rentokil to “Buy” from “Neutral” and raised its 12-month price target to 590 pence from 515 pence. This implies around 33% upside potential compared with the previous closing price. For investors, this is a signal that the pest control company, which has gone through a difficult period after acquiring Terminix, is finally beginning to recover.
So what has changed? The main factor is improving operating performance in North America, Rentokil’s largest market. After several years of instability related to the integration of Terminix, the company has begun to steadily restore organic growth. Goldman Sachs expects the business to return to mid-single-digit organic growth by 2027, narrowing the performance gap with industry rival Rollins.
The broker also noted that the suspension of the main Terminix integration work reduced operational disruptions, allowing management to focus on improving execution while gradually expanding margins. The group’s EBITA margin is expected to rise to 17.1% in 2027.
Let’s take a closer look at what is really happening with Rentokil, why Goldman Sachs upgraded the stock, and what this means for investors.
What Is Rentokil Initial and Why Does It Matter?
Pest Control and More
Rentokil Initial is not just a company that eliminates rats and cockroaches. It is a global giant in the hygiene and sanitation services sector, operating in dozens of countries around the world. Its services include pest control, workplace hygiene,...
